Defective phosphatidylinositol 3-kinase signaling in central control of cardiovascular effects in the nucleus tractus solitarii of spontaneously hypertensive rats

Hypertension Research

Volumn 31, Issue 6, 2008, Pages 1209-1218

  Hsiao, Michael ^a,b   Lu, Pei Jung ^a,c   Huang, Hsiao Ning ^a   Lo, Wan Chen ^a   Ho, Wen Yu ^a,d   Lai, Tsung Ching ^b   Chiang, Hung Ting ^c   Tseng, Ching Jiunn ^a,c  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b GENOMICS RESEARCH CENTER   (Taiwan)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Central cardiovascular regulation; Insulin; Nucleus tractus solitarii; Phosphatidylinositol 3 kinase; Spontaneously hypertensive rat

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; INSULIN RECEPTOR SUBSTRATE 3; INSULIN RECEPTOR SUBSTRATE 4; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PROTEIN KINASE B; URETHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; BRADYCARDIA; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART RATE; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PROTEIN FUNCTION; RAT; RISK FACTOR; SIGNAL TRANSDUCTION; SOLITARY TRACT NUCLEUS; SPONTANEOUSLY HYPERTENSIVE RAT; WESTERN BLOTTING; WISTAR KYOTO RAT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BLOOD PRESSURE; CHROMONES; HEART RATE; INSULIN; MALE; MORPHOLINES; NG-NITROARGININE METHYL ESTER; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; SOLITARY NUCLEUS;

EID: 48349104934     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.1209     Document Type: Article

References (26)

1. Rupp H, Brilla CG: Experimental types of hypertension - models for essential hypertension in the human? Herz 1995; 20: 315-321.
2. Werther GA, Hogg A, Oldfield BJ, et al: Localization and characterization of insulin receptors in rat brain and pituitary gland using in vitro autoradiography and computerized densitometry. Endocrinology 1987; 121: 1562-1570.
3. Huang HN, Lu PJ, Lo WC, Lin CH, Hsiao M, Tseng CJ: In situ Akt phosphorylation in the nucleus tractus solitarii is involved in central control of blood pressure and heart rate. Circulation 2004; 110: 2476-2483.
4. Okamoto K, Aoki K: Developmemof a strain of spontaneously hypertensive rats. Jpn Circ J 1963; 27: 282-293.
5. Haeusler G, Finch L, Thoenen H: Central adrenergic neurones and the initiation and development of experimental hypertension. Experientia 1972; 28: 1200-1203.
6. Aitman TJ, Glazier AM, Wallace CA, et al: Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 1999; 21: 76-83.
7. Potenza MA, Marasciulo FL, Chieppa DM, et al: Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production. Am J Physiol Heart Circ Physiol 2005; 289: H813-H822.
8. Shankar RR, Wu Y, Shen HQ, Zhu JS, Baron AD: Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes 2000; 49: 684-687.
9. Hingorani AD, Liang CF, Fatibene J, et al: A common variant of the endothelial nitric oxide synthase (Glu298→Asp) is a major risk factor for coronary artery disease in the UK. Circulation 1999; 100: 11515-1520.
10. Cusi K, Maezono K, Osman A, et al: Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 2000; 105: 311-320.
11. Sugita M, Sugita H, Kaneki M: Increased insulin receptor substrate 1 serine phospborylation and stress-activated protein kinase/c-Jun N-terminal kinase activation associated with vascular insulin resistanee in spontaneously hypertensive rats. Hypertension 2004; 44: 484-489.
12. Tseng CJ, Liu HY, Lin HC, Ger LP, Tung CS, Yen MH: Cardiovascular effects of nitric oxide in the brain stem nuclei of rats. Hypertension 1996; 27: 36-42.
13. Vaziri ND, Ni Z, Oveisi F: Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension 1998; 31: 1248-1254.
14. Lo WC, Lu PJ, Ho WY, Hsia M, Tseng CJ: Induction of heme oxygenase-1 is involved in carbon monoxide-mediated central cardiovascular regulation. J Pharmacol Exp Ther 2006; 318: 8-16.
15. Schubert M, Gautam D, Sudo D, et al: Role for neuronal insulin resistance in neurodegenerative diseases. Proc Natl Acad Sci U S A 2004; 101: 3100-3105.
16. Moroo I, Yamada T, Makino H, et al: Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease. Acta Neuropathol 1994; 87: 343-348.
17. Avidor R, Eilam R, Malach R, Gozes I: VIP-mRNA is increased in hypertensive rats. Brain Res 1989; 503: 304-307.
18. Aitman TJ, Gotoda T, Evans AL, et al: Quantitative trait loci for cellular defects in glucose and fatty acid metabolism in hypertensive rats. Nat Genet 1997; 16: 197-201.
19. Kwok JB, Kapoor R, Gotoda T, et al: A missense mutation in kynurenine aminotransferase-1 in spontaneously hypertensive rats. J Biol Chem 2002; 277: 35779-35782.
20. Abe H, Yamada N, Kamata K, et al: Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-. J Clin Invest 1998; 101: 1784-1788.
21. Scherrer U, Sartori C: Detective nitric oxide synthesis: a link between metabolic insulin resistance, sympathetic overactivity and cardiovascular morbidity. Eur J Endocrinol 2000; 142, 315-323.
22. Ito K. Hirooka Y, Sakai K. et al: Rho/Kho-kinase pathway in brain stern contributes to blood pressure regulation via sympathetic nervous system: possible involvement in neural mechanisms of hypertension. Circ Res 2003; 92: 1337-1343.
23. Makris T, Krespi P, Triposkiadis F, Voltreas V, Hatzizaharias A, Kyriakidis M: Insulin receptor number in arterial hypertension: response to treatment with fosinopril or atenolol. Am J Hypertens 1998; 11: 494-496.
24. Morris BJ: Insulin receptor gene in hypertension. Clin Exp Hypertens 1997; 19: 551-565.
25. Yang H, Raizada MK: Role of phosphatidylinositol 3-kinase in angiotensin II regulation of neuropinephrine neuromodulation in brain neurons of the spontaneously hypertensive rat. J Neurosci 1999; 19: 2413-2423.
26. Rahmouni K, Morgan DA, Morgan GM, et al: Hypothalamic P13K and MAPK differentially mediate regional sympathethic activation to insulin. J Clin Invest 2004; 114: 652-658.